Pharmacy OneSource Blog

Upcoming Webinar with Eric Kastango and Kate Douglass- CriticalPoint’s USP <800> 2017 Study Results: An Initial Roadmap to Compliance

Posted on 02/08/18

Compounding in bunnysuits.jpg
Join Eric S. Kastango, RPh, MBA, FASHP and Kate Douglass, MS, RN, CRNI for:

CriticalPoint’s USP <800> 2017 Study Results: An Initial Roadmap to Compliance Webinar
Wednesday, February 21, 2018
12:00 noon Eastern
Register

USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings provides standards for the safe handling of hazardous drugs to reduce the risk of exposure to health care personnel, patients, their families, and the health care environment. Focusing on staff safety, USP <800> is based on well-established, replicated data. Contrary to popular thought, the chapter does not represent new thinking; rather, it establishes reasonable and long overdue requirements to protect staff who must handle these drugs to provide care to their patients.

Although initially published in 2016, and originally scheduled to become officially enforceable July 1, 2018, USP decided to delay the chapter’s official enforcement date until December 1, 2019. CriticalPoint added USP 800 Compliance items to its long standing USP 797 Compliance Study. This webinar will discuss an overview of findings, however Eric Kastango and Kate Douglass will focus on an explanation of CriticalPoint’s Initial Roadmap to USP <800> Compliance, which uses five specific Key Performance Elements (KPEs) that come directly from USP <800> as a guide to an organization’s pursuit of staff and workplace safety.

About the Presenters

Kate Douglass, MS, RN, CRNI is Vice-President of CriticalPoint, LLC, a healthcare training and development company. She is a co-author of CriticalPoint’s Interactive USP Chapter <797> Gap Analysis Tool and Co-Director of the annual USP 797 Compliance Study. Kate has written numerous articles on sterile compounding quality and training. She co-authored a paper commissioned by the Pew Charitable Trust titled Quality Standards for Large-Scale Sterile Compounding Facilities and is a member of the Sterile Compounding Boot Camp Faculty. Kate has personally supervised the design, engineering and build of pharmacy compounding facilities that met or exceeded USP requirements. She was the Project Manager for the design and build of CriticalPoint’s Center for Training and Research in Totowa, New Jersey.

Eric S. Kastango, M.B.A., B.S.Pharm., FASHP is president of Clinical IQ LLC, a health care consulting firm and CriticalPoint, LLC, a web-based education company. Eric received a coveted ISMP Cheers Award in 2015 for his work related to sterile compounding safety. He is one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award that recognized his efforts and assistance to the states and NABP to address the compounding tragedy that occurred in 2012.

Topics: Sterile Compounding

About the Author

N/A